Shweta Vadhavkar Selected Research

Shweta Vadhavkar Research Topics

5	Neoplasms (Cancer) 01/2023 - 12/2020
5	Asthma (Bronchial Asthma) 01/2022 - 10/2017
3	Breast Neoplasms (Breast Cancer) 01/2019 - 12/2017
2	Inflammation (Inflammations) 01/2022 - 10/2017
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023
1	Infections 01/2022
1	Neutropenia 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Nasal Polyps (Nasal Polyp) 12/2021
1	Body Weight (Weight, Body) 12/2021
1	Polyps 12/2021
1	Chronic Urticaria 12/2021
1	Rhinosinusitis 12/2021
1	Neoplasm Metastasis (Metastasis) 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 09/2021
1	Airway Obstruction (Choking) 10/2017

5	atezolizumabIBA 01/2023 - 12/2020
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2017
3	Ado-Trastuzumab EmtansineIBA 01/2019 - 12/2017
2	Bevacizumab (Avastin)FDA Link 01/2023 - 09/2021
2	Monoclonal AntibodiesIBA 01/2022 - 10/2017
2	AlbuminsIBA 01/2022 - 10/2021
2	astegolimabIBA 01/2022 - 10/2021
2	human ERBB2 proteinIBA 01/2019 - 12/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Gemcitabine FDA Link 01/2023
1	obinutuzumabIBA 01/2022
1	venetoclaxIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	CytokinesIBA 01/2022
1	Janus Kinase 1IBA 01/2022
1	Immunoglobulin E (IgE)IBA 12/2021
1	Omalizumab (Xolair)FDA Link 12/2021
1	C-Reactive ProteinIBA 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021
1	Biological FactorsIBA 12/2020
1	pertuzumabIBA 01/2019
1	Capecitabine (Xeloda)FDA Link 12/2017
1	ErbB Receptors (EGF Receptor)IBA 12/2017
1	Lapatinib (GW572016)FDA Link 12/2017
1	taxaneIBA 12/2017
1	Trastuzumab (Herceptin)FDA Link 12/2017
1	Interleukin-13IBA 10/2017
1	lebrikizumabIBA 10/2017

2	Therapeutics 11/2022 - 12/2017